Partial Opioids: Medications for the Treatment of Pain and Drug Abuse
Spinal and Supraspinal Mechanisms of Neuropathic Pain
A Third Life for Burimamide: Discovery and Characterization of a Novel Class of Non-Opioid Analgesics Derived from Histamine Antagonists
Peripheral Opioid Modulation of Visceral Paina
Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development
Development of Novel Medications for Drug Addiction: The Legacy of an African Shrub
Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies
Effects of the Novel D1 Dopamine Receptor Agonist ABT-431 on Cocaine Self-Administration and Reinstatement
GABA Modulation of Cocaine Self-Administration
Application of Artificial Enzymes to the Problem of Cocaine
Neurobiology of Addiction: Toward the Development of New Therapies
Methadone-Related Opioid Agonist Pharmacotherapy for Heroin Addiction: History, Recent Molecular and Neurochemical Research and Future in Mainstream Medicine
Prenatal Cocaine Exposure
Mimicking Gene Defects to Treat Drug Dependence
Tobacco Dependence: Global Public Health Potential for New Medications Development and Indications
Ibogaine in Acute Opioid Withdrawal: An Open Label Case Series
Methamphetamine Quantitative Urine Concentrations during a Controlled Trial of Fluoxetine Treatment: Preliminary Analysis
Pharmacological Profiles of Kappa Opioids: Correlation between [35S]GTPγS Binding and Cyclic AMP Production
Modification of the Discriminative Stimulus Effects of Cocaine by the Nitric Oxide Synthase Inhibitor L-NAME
Synchronous Activity in the Ventral Tegmental Area and Prefrontal Cortex
Histamine Modulation of Nucleus Accumbens Neurons
Dopaminergic Mechanisms in Relapse to Cocaine-Seeking Behavior: Implications for Medications Development
18-Methoxycoronaridine Differentially Alters the Sensitized Behavioral and Dopaminergic Responses to Repeated Cocaine and Morphine Administration: Implications for Sensitization in the Mediation of Drug Addiction